Heart failure (HF) is a costly and growing health problem that is routinely complicated by chronic pain and depression. The purpose of this paper is to describe the characteristics of pain and pain management in depressed HF patients. In this descriptive cross-sectional study, we analyzed data from 62 participants with depression and class II-IV HF. Study variables of interest were collected from the Brief Pain Inventory, Beck Depression Inventory, and Rand-36. Almost all participants (98%) had some pain in the past month and most had pain in the last 24 hours (66%). The median pain score was 4 (0-10 scale) with the majority reporting moderate to severe pain. The median pain interference score was 4.42 (0-10 scale) with the majority reporting moderate to extreme interference. Medication to treat pain was used by all participants who reported pain, with only 5% also using nonpharmacologic treatment. The majority of participants reported moderate or severe pain while also having moderate to extreme pain interference. Nonpharmacologic pain treatments were severely underused. Women were more likely to have higher levels of pain intensity and more pain interference than men, suggesting that additional screening for the impact of pain is especially important in women. The wide variety of body areas affected, along with moderate to high intensity pain and considerable interference scores reported, indicate that pain was ineffectively treated. Nonpharmacologic treatments should be considered to decrease the impact of pain.
INTRODUCTION
Heart failure (HF) is a costly and growing health problem that is routinely complicated by chronic pain and depression (Evangelista, Sackett, & Dracup, 2009) .
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Noncardiac pain is not routinely assessed by cardiac health care providers, but is present in the majority (67%) of patients with HF and is common in all stages of HF . The most common causes of noncardiac pain are degenerative joint disease and arthritis Goodlin et al., 2012; Hunt et al., 2009 ). Musculoskeletal pain is commonly treated with prescription and over the counter nonsteroidal anti-inflammatory drugs (NSAIDS). NSAIDS are contraindicated in HF patients due to increased fluid retention, edema and increased blood pressure leading to increased hospitalizations (Hillis, 2002) . Also, NSAIDS increase the risk of additional cardiac events so much so that the U.S. food and drug administration has strengthened the warning label on NSAIDs (Hossain, 2015; Ong, Ong, Tan, & Chean, 2013) .
Depression is common among patients with HF, as 22 to 42% are diagnosed with clinically significant depression (Rutledge, Reis, Linke, Greenberg, & Mills, 2006; Turvey, Schultz, Arndt, Wallace, & Herzog, 2002) . With the addition of comorbid depression, HF patients have increased hospitalizations, poorer selfcare behaviors, and higher rates of death (Kato et al., 2012) . In a study examining the prevalence of pain in HF patients, 38% of HF patients had pain and depression which markedly increased illness burden (Goodlin et al., 2012; Poole, White, Blake, Murphy, & Bramwell, 2009 ). When depression is combined with HF and pain, patients are even less able to follow recommendations, treatment plans and engage in selfcare behaviors, and length of time to treat chronic pain and depression is extended.
The purpose of this paper is to examine the characteristics of pain in patients with depression and HF. The main research questions (aims) include: (1) How many patients with HF and depression report pain and does pain presence differ based on demographic variables and health related characteristics? (2) What is the pain intensity and pain interference reported by depressed HF patients? (3) Is there a difference in pain intensity and pain interference based on depression level categories among HF patients? (4) What body areas do depressed HF patients report as causing pain? (5) What treatments do depressed HF patients use to manage their pain and what is their perceived effectiveness?
Design
The sample (n ¼ 62) is a subset of participants who were enrolled in the COPE (Combined Illness Management and Psychotherapy in Treating Depressed Elders) trial from August 2012 through December 2014. The study is a two-arm randomized controlled trial in which the efficacy of an interpersonal psychotherapy-based treatment combined with chronic illness management is compared with a chronic illness management only. Participants were recruited from a tertiary medical center, Veterans Administration medical center, and federally qualified health center in the U.S. Midwest. Participants could also be referred from clinic personnel or self-refer from advertisements.
Participants
Patients were eligible for the study if they were 55 or older, diagnosed with heart failure (HF) or chronic obstructive pulmonary disease (excluded from this analysis), and endorsed depressive symptoms (scoring $10 on the Beck Depression Inventory II). Diagnosis of HF was based on radiographic evidence of an ejection fraction #40% or documented response to HF medication regimens based on chart review. Patients needed to present with functional impairment indicated by a score of #70 on the physical impairment subscale of the Rand Medical Outcomes Study 36-Item Short Form Survey Instrument (Rand-36).
Exclusion criteria included currently participating in psychotherapy (part of the study intervention), other significant psychiatric diagnoses (e.g., bipolar disorder, schizophrenia, substance abuse, etc.), suicidal ideation with plan or intent, cognitive impairment (documented in medical record or Mini-Mental State Examination score # 23), awaiting transplant, residence in a long-term care facility, or significant hearing impairment that limited ability to participate in phone conversations (the study intervention is based on using the phone).
METHODS
In this descriptive, cross-sectional design, preintervention assessment data from depressed HF participants along with pain assessment scales were added to data collection instruments. All data were collected by research assistants who were trained and supervised by the principal investigator; all study procedures were approved by the affiliated Institutional Review Boards. Written informed consent for this secondary analysis was included as part of the parent project because the additional instruments were added to the original study procedure while recruitment was ongoing.
Instruments/Measures
The Beck Depression Inventory II (BDI-II) was used to assess level of depression. The BDI-II contains 21 questions that are scored on a scale value of 0-3 for a total score range of 0-63. The BDI is recommended for chronic pain clinical trials by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) (Dworkin et al., 2008) .
The Brief Pain Inventory-Short Form (BPI-SF) was used to assess pain intensity and interference in the past 24 hours along with currently used pain management therapies. The BPI-SF assesses presence of pain, intensity of pain, current treatments being used, perceived pain relief from treatments, and extent that pain interferes with daily living (Kapstad, Rokne, & Stavem, 2010; Mendoza, Mayne, Rublee, & Cleeland, 2006) . The 15-item BPI-SF was developed for cancer pain patients but has been reported to have consistent validity and reliability for many conditions (Kumar, 2011) . The BPI-SF is recommended by IMMPACT for chronic pain clinical trials (Furlanetto, Mendlowicz, & Romildo Bueno, 2005) .
The Rand-36, Version 2, was used to measure health-related quality of life. The Rand-36 is composed of 36 items that assess eight health concepts: physical functioning, role limitations caused by emotional problems, role limitations caused by physical health, social functioning, mental health, energy/fatigue, pain, and general health perceptions (McHorney, Ware, & Raczek, 1993) . The Rand-36 is perhaps the most widely used health-related quality of life survey and has well-documented reliability exceeding . 90 and validity .80-.90 (McHorney et al., 1993) .
A demographic and health-related questionnaire was developed to obtain data on personal characteristics. Demographic variables included age, gender, ethnicity, race, marital status, income level, health insurance, employment status, veteran status, and education level. Health characteristics assessed include depression level, HF classification, smoking status, and antidepressant use. Also, the Charlson Comorbidity Index was used to describe the sample as part of the health characteristics of participants. Higher scores are associated with greater likelihood of mortality or higher resource use (Charlson, Pompei, Ales, & MacKenzie, 1987) .
Statistical Analyses
Data were analyzed using SAS (Version 9.3, SAS Institute Inc., Cary, NC). Summary statistics were created for the variables of interest. This included frequency counts, percentages, means, standard deviations, and quartile values. Demographic variables were compared among individuals with and without pain and for those with mild, moderate, and severe pain intensity and interference. Depression categories were scored with 14-19 as mild, 20-28 as moderate, and 29þ severe on the BDI-II (Beck, Epstein, Brown, & Steer, 1988) . To determine differences between these categories, Fisher's exact test was used when there was not an expected count of at least 5 cases per category; c 2 was used when there was an expected count of at least 5 cases per category; and Mantel-Haenszel was used when there was an expected count of at least 5 in each category and the variable was an ordinal. The power analysis was conducted using the statistical program G*Power (Faul, Erdfelder, Lang, & Buchner, 2007) and indicated that 52 participants were needed to find statistically significant differences with a at .05 (type 1 error), b at .80 (power), and effect size at .35.
RESULTS
Data from 62 depressed HF participants were analyzed for this study. Mean age was 67.4 years (standard deviation [SD] ¼ 8.8). The majority of the participants were male, white, non-Hispanic, married individuals with some college education and an annual income <$20,000. The mean Charlson Comorbidity Index Score with HF diagnosis not counted (because all patients had HF) was 5.37 with a standard deviation of 2.289. Most had an HF classification of stage III, were not current smokers, and did not take antidepressant medications (Table 1) .
The majority (66%) of participants experienced pain in the last 24 hours. Differences in presence of pain by demographic and health-related variables are reported in Table 1 . There were no statistically significant differences in pain frequencies between any of the demographic groups (p $ .05). After BPI-SF scoring instructions, the four pain intensity questions and seven interference items were averaged to derive a single overall score for each. The median score for pain intensity was 4.0 (items rated 0-10) with an interquartile range of 1.75-6.25. The median for pain interference was 4.42 (items rated 0-10) an interquartile range from 0-6.7. Median scores of 4 and 4.42 indicate a moderate amount of pain intensity and pain interference, respectively. The interquartile ranges indicate the wide variability of pain experiences in this sample.
Pain intensity scores from the BPI-SF were categorized as no pain/mild pain (0-3), moderate pain (4-6), and severe pain (7-10). Analyses identified significant and trends toward differences between pain severity categories for gender (p ¼ .04), race (p ¼ .06), and health insurance status (p ¼ .03), as reported in Table 2 . Women were more likely to report higher pain intensity then men (p ¼ .04). There were no differences based on depression level or HF classifications.
Pain interference was categorized as no pain interference/mild pain interference (0-3) moderate pain interference (4-6), and severe pain interference and Mantel-Haenszel was used when there were at least five in each category and an order to both variables.
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(7-10). As shown in Table 3 , women reported significantly greater interference than men (p ¼ .04). Depression level and HF classification did not differ significantly between these groups. Areas of the body most commonly reported as painful were the back, hips/upper legs, and lower legs, suggesting that noncardiac pain was common (see Table 4 ). By comparison, pain in the chest, neck, or shoulders that might represent heart-related pain was less often reported. Only 30 participants marked an area of the body that was painful, and of those 22% reported more than one area was painful.
Thirty of 62 participants (48%) provided a response for pain treatments used. The vast majority (95%) reported using only medications. Opioids were the most commonly reported medication used, followed by acetaminophen (Tables 5 and 6 ). Only two participants reported doing something in addition to and Mantel-Haenszel was used when there were at least five in each category and an order to both variables.
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Characteristics of Pain taking pain medication. One person reported going to physical therapy and a chiropractor and another participant reported going to the chiropractor and using a heating pad. Opioid medication use by the area of body pain reported revealed that oxycodone and tramadol were the most commonly used drugs for low back and knee pain (Table 6 ). Of the 13 reports of low back pain, 7 participants reported using hydrocodone, 5 used tramadol, and 1 used another medication. Among the 10 who reported knee pain, 5 used hydrocodone, 3 used tramadol, and 2 used other medications. Of note, participants who reported use of opioids (Table 6) reported from 1 to 8 locations of pain, with a range of 5 to 10 for their worst pain level (on a scale of 1-10).
Fifty-six participants responded to the question ''How much relief did you get from the pain management strategies you used?'' Of those reporting, the majority (56%) had little or no relief. Of note, most of those who reported no pain in the last 24 hours also reported no relief from pain treatments or medications (n ¼ 16); thus only four people who had pain reported little or no pain relief from their pain management treatment of choice. A total of 28% (n ¼ 16) reported 70%-100% relief, 16% (n ¼ 9) reported 40%-60% relief, and 20% (n ¼ 11) reported 10%-30% relief.
DISCUSSION
Patients with HF and depression report high prevalence of pain that interferes with their function and quality of life. In this study, almost all participants had some pain in the past month (98%) and most had pain in the last 24 hours (66%). This is consistent with other limited reports in the literature Nahin, 2015; Park, Clement, Hooyman, Cavalie, & Ouslander, 2015) . Although other studies of HF patients did not include only those with depression, this study found a similar prevalence of pain compared with HF patients in general (Goodlin et al., 2012) . Studies of the general U.S. population indicate that 31% of adults report having pain in the last 3 months (Johannes, Le, Zhou, Johnston, & Dworkin, 2010) , which is roughly half the rate reported by participants in this study. However, when age categories in the general population are considered, these findings are similar to rates of 40%-63% among adults aged 65 and older (Johannes et al., 2010; Nahin, 2015) .
The more important finding is that depressed HF patients reported all areas of the body as sources of pain. Although the common pain locations typically reported by older adults were present in this study, less common sources of pain were also reported. Of the few studies that have reported on locations of pain in HF patients, Goodlin et al. (2012) found below the knees most common (38%), followed by the lower back (31%), whereas the present study found back pain was most common (37%), followed by hips/upper thighs (18%). Goebel et al. (2009) grouped arms, legs, and joints together and found 71% of HF participants reported those areas, with the back area reported by 55%. It is difficult to make direct comparisons because the body area groupings are different or only certain areas were reported. Despite this problem it seems clear that a thorough pain assessment is indicated to ensure that pain is accurately identified, discussed with patients, and treated appropriately. For example, decreased heart function may cause pain in areas of the chest, stomach, and/or lower legs that may require additional HF treatment. Pain in the back, lower legs, and shoulders could be due to other causes, such as arthritis, previous injuries, or peripheral vascular disease, and may have very different treatment options based on causal factors. In short, thorough assessment is critical to determining underlying causes and the best treatment options.
Perhaps the most important finding related to pain treatment, however, was the reliance on medications and lack of alternative pain treatments reported. Combining pharmacologic and nonpharmacologic treatments is recommended by the American Chronic Pain Association as best practice but was rarely reported by participants (Feinberg et al., 2015) . This finding is alarming in light of the levels of pain intensity and interference that were reported while using medication interventions. Only one study was found that looked at alternative pain treatment practices in HF patients. Because that study required participants to currently use alternative pain treatments before being enrolled in the study, we are unable to assess how many HF pain patients had pain but did not use alternative pain treatments (McDonald, Soutar, Chan, & Afriyie, 2015) . With that said, the study did find 25 hospitalized HF participants who were using alternative treatments and 18 combined medications with the alternative treatment. Potential nonpharmacologic pain treatments that have been found to have some benefit, depending on the cause of pain, include acupuncture, reflexology, aroma therapy, music therapy, dance therapy, yoga, hypnosis, relaxation and imagery, distraction and cognitive reframing, psychotherapy, peer support group, spiritual, chiropractic, magnet therapy, biofeedback, meditation, and relaxation techniques (Health Care Association of New Jersey, 2006; Hochberg et al., 2012; McDonald et al., 2015) . In short, wide varieties of options exist but must be specifically tailored to the person, his or her characteristics and abilities, and the type of pain the person experiences.
For those who reported pain, the experience had an important impact on their daily lives as illustrated by median score of 4.42 for pain interference. This finding is consistent with the report by Goodlin et al. (2012) of a mean interference score of 4.0 (0-10 scale) in patients with advanced HF where 38% also had significant depressive symptoms. Another important finding was that HF patients with higher depression scores did not have significantly different pain intensity or interference scores than those with lower depression scores. This finding is inconsistent with a considerable body of literature supporting the strong relationship between chronic pain and depression (Arnow et al., 2009; Bair, Robinson, Katon, & Kroenke, 2003; Gambassi, 2009; Poole et al., 2009; Thielke, Fan, Sullivan, & Unutzer, 2007) . These studies found that the presence of depression intensifies pain experiences. Several explanations for the lack of difference identified in this sample are possible. Because clinical depression was part of the inclusion Reports of pain location in this sample support the presence of multiple noncardiac sites of chronic pain that can affect life activities. This study's findings of back pain (37%), pain in the hips/upper legs (18%), and pain in the knees/lower legs (15%) are consistent with other reports (Johannes et al., 2010) . Findings related to pain treatments used by depressed HF patients reinforce the existing literature that medications with known risks are used. Opioids were the most commonly used type, followed by acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs). These trends are consistent with McDonald's findings related to analgesic use in hospitalized HF patients, and level of opioid use was similar to that reported by others (Goodlin et al., 2012; McDonald et al., 2015; Toblin, Mack, Perveen, & Paulozzi, 2011) . Because of known adverse effects of opioids and NSAIDs, careful evaluation of the appropriateness of patients' medication pain treatment plan is essential. Education regarding the risks and benefits of medications appears to be needed, as well as discussion of various types of nonpharmacologic pain treatments that may be effective with less risk for the patient. Education on contraindications and risks related to NSAID use, in particular, should be part of routine HF care, particularly because these medications are available over the counter and thus may be viewed as being ''harmless'' by patients.
Limitations
The data for this study were collected during an ongoing study that focused on both HF and chronic obstructive pulmonary disease, which influenced the number of HF participants available in the time frame of this study. The inclusion criteria of having a depressive disorder limited analyses to examination of pain experience by levels of depression and thus did not allow comparison of those with and without depression. Recruitment was conducted in an area of low racial and ethnic diversity so the majority of participants were Caucasian Americans. Therefore, the results of this study may not reflect the pain characteristics of other ethnic and racial populations. In addition, the data collection procedures did not allow for interviewing the participants.
Nursing Implications
The majority of participants had moderate to severe pain intensity and pain interference. This important finding indicates why all patients need to have a thorough pain assessment. The wide variety of pain sites noted by this sample suggests many different causes of pain that will likely respond better to a variety of treatments. Because HF providers tend to focus on cardiac pain, patients are often educated about what to do for that type of pain but not others. Furthermore, making referrals to obtain the most effective treatment plan, with additional follow-up to ensure the best pain management is achieved, will likely improve numerous outcomes for patients. Referrals to pain specialists, physical therapy, chiropractors, occupational therapy, or cardiac rehabilitation, as is appropriate for each patient's care, have the potential to decrease pain intensity, pain interference, depression symptoms, and issues around managing activities of daily living and improve quality of life.
Although NSAIDs are contraindicated for HF patients, they were used by some of the participants. Clinicians need to ask specifically about NSAIDs, as well as what other treatments patients are using as part of their pain assessment. Although it is possible that the clinicians thought NSAIDs were the best pain treatment option for participants in the study, it is more likely that the clinician was unaware of NSAID use because they can be bought without a prescription (i.e., over the counter). For example, the person may have used the medication intermittently over a long period for musculoskeletal pain but now has HF, which increases risks of untoward side effects. In the absence of a specific medication review that includes occasional use of over-the-counter medications, contraindicated medication use may go undetected. The other possibility is that providers are unaware of the contraindication.
Lastly, nonpharmacologic pain interventions are recommended in best practice guidelines but are a neglected source of relief for the patients in this sample. Greater knowledge among clinicians of treatment options and resources in the community is an important first step in their making needed referrals. Of equal importance, the amount of pain interference was moderately high in spite of using pharmacologic pain treatments. This finding suggests that pain medications are not enough by themselves to keep pain interference in the mild range and thus alternative pain treatments are needed to assist patients in managing their pain.
